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Summary
Background.  —  Brugada  syndrome  is  a  genetic  heart  disease  with  autosomal  dominant  inher-
itance. Family  screening  commonly  detects  one  parent  responsible  for  transmission  of  the
disease.
Aims. —  To  describe  atypical  transmission  of  Brugada  syndrome.
Methods.  —  Between  2001  and  2007,  systematic  screening,  including  an  electrocardiogram,
ajmaline  challenge  and  DNA  sequencing  of  the  SCN5A  gene,  of  the  ﬁrst-degree  relatives  of
62 probands  with  Brugada  syndrome  was  performed  (Programme  Hospitalier  de  Recherche
Clinique).
Results. —  In  two  families,  both  parents  transmitted  Brugada  syndrome  to  their  offspring.  In  the
ﬁrst family,  the  proband  presented  Brugada  electrocardiogram  features  with  ajmaline  challenge
and carried  a  new  SCN5A  mutation  (p.V1281F).  The  mutation  was  also  identiﬁed  in  the  mother,
who had  a  type  1  aspect  on  inferior  leads  with  ajmaline.  The  proband’s  father  presented  a
typical Brugada  electrocardiogram  pattern  on  lead  V2  with  ajmaline  and  no  SCN5A  gene  muta-
tion. In  the  second  family,  the  proband  was  a  boy  aged  2.5  years  who  had  been  resuscitated
from sudden  cardiac  death.  Ajmaline  challenge  revealed  a  typical  Brugada  electrocardiogram
pattern in  both  parents  but  with  no  mutation  in  the  genes  studied.
Abbreviations: BS, Brugada syndrome; ECG, electrocardiogram; LQTS, long QT syndrome.
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Conclusion.  —  Family  studies  should  always  be  exhaustive  and  discovery  of  one  parent  with
Brugada syndrome  does  not  eliminate  the  need  for  screening  of  the  other  parent.
© 2013  Published  by  Elsevier  Masson  SAS.
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Résumé
Contexte.  —  Le  syndrome  de  Brugada  est  une  maladie  cardiaque  génétique  dont  la  transmission
est autosomique  dominante.  L’enquête  familiale  détecte  fréquemment  un  parent  à  l’origine  de
la transmission  de  la  maladie.
Objectifs.  —  Décrire  un  mode  de  transmission  atypique  dans  le  syndrome  de  Brugada
Méthodes.  — Entre  2001  et  2007,  une  enquête  systématique  comprenant  un  ECG,  un  test  à
l’ajmaline  et  un  séquenc¸age  du  gène  SCN5A  a  été  réalisée  chez  les  apparentés  au  premier
degré de  62  patients  porteurs  d’un  syndrome  de  Brugada  (Programme  Hospitalier  de  Recherche
Clinique).
Résultats.  —  Dans  deux  familles,  les  deux  parents  sont  apparus  avoir  transmis  le  syndrome  de
Brugada à  leur  descendance.  Dans  la  première  famille,  le  propositus  avait  un  aspect  ECG  de
Brugada lors  du  test  à  l’ajmaline  et  une  mutation  non  décrite  de  SCN5A  (p.V1281F).  La  mutation
a été  identiﬁée  également  chez  la  mère  qui  avait  un  aspect  de  type  1  dans  les  dérivations
inférieures  lors  du  test  à  l’ajmaline.  Le  père  du  propositus  avait  un  aspect  typique  de  Brugada
en V2  lors  du  test  à  l’ajmaline  mais  pas  de  mutation  de  SCN5A.  Dans  la  seconde  famille,  le
propositus  était  un  garc¸on  de  deux  ans  et  demi,  ressuscité  d’une  mort  subite  cardiaque.  Le
test à  l’ajmaline  a  montré  un  aspect  ECG  typique  de  Brugada  chez  les  deux  parents  mais  sans
mutation dans  les  gènes  étudiés.
Conclusion.  —  Les  études  familiales  doivent  être  toujours  exhaustives  dans  le  syndrome  de  Bru-
gada et  la  découverte  d’un  des  deux  parents  atteint  ne  doit  pas  éliminer  la  nécessité  d’explorer
le second  parent.
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Background
Brugada  syndrome  (BS)  is  a  genetic  heart  disease  with  auto-
somal  dominant  inheritance  [1].  In  about  15—20%  of  cases
the  disease  is  related  to  a  mutation  in  SCN5A, which  encodes
the  alpha  subunit  of  the  sodium  ion  channel  [2].  Inheritance
of  the  disease  can  be  demonstrated  in  two-thirds  of  patients
[3]  but  penetrance  and  expressivity  of  the  disease  is  highly
variable,  ranging  from  a  lifelong  asymptomatic  course  to
sudden  cardiac  death  in  the  ﬁrst  year  of  life.
We  report  two  families  presenting  dual  transmission  of
the  BS  phenotype.
Methods
The  two  cases  were  detected  during  a  prospective  evalua-
tion  of  the  familial  prevalence  of  BS,  involving  62  families
(Programme  Hospitalier  de  Recherche  Clinique).  The  results
of  the  screening  of  the  62  families  have  been  published
elsewhere  [3].
Results
First family
A  19-year-old  male  of  Caucasian  origin  was  referred  to  our
hospital  for  suspicion  of  BS  following  a  routine  electro-
cardiogram  (ECG)  that  revealed  a  type  2  Brugada  ECG  in
the  right  precordial  leads  (Fig.  1).  This  was  in  the  con-
text  of  attempted  suicide  with  ibuprofen.  The  patient  had
a
f
vn  SAS.
o  history  of  arrhythmia  and  no  familial  history  of  sud-
en  death;  he  had  been  previously  treated  for  epilepsy.
chocardiography,  hematology  and  biochemistry  examina-
ions  yielded  normal  ﬁndings.
ECG  with  right  precordial  leads  in  the  second  intercostal
paces,  high  V1—V2  (Fig.  1, II1),  revealed  ST-segment  ele-
ation  in  the  high  V2  lead  (coved-type).  Ajmaline  injection
1  mg/kg  administered  over  10  minutes)  induced  coved  ST-
egment  elevation  in  the  right  precordial  leads  (V1,  V2,  in
he  fourth  intercostal  space)  and  a  J  wave  in  the  inferior
eads.  SCN5A  gene  analysis  revealed  a  G  to  T  mutation  in
osition  3841  of  the  coding  sequence  (CCDS46799.1  nomen-
lature)  leading  to  a  valine  to  phenylalanine  replacement  in
osition  1281  of  the  protein  (p.V1281F).  A  molecular  mod-
lling  study  was  performed  as  previously  described  [4]  and
evealed  that  the  mutation  introduced  a  loss  of  ﬂexibility
n  the  helix  structure  from  residues  1272  to  1289  due  to
ncreased  aliphatic  properties.  The  proband  was  heterozy-
ous  for  this  mutation.  Family  screening  revealed  that  the
ather  (aged  43  years)  had  a  history  of  epilepsy.  A  type  2  ECG
attern  was  observed  at  rest  (Fig.  1, I1).  Ajmaline  challenge
evealed  accentuation  of  ST-segment  elevation  in  the  V2
ead  from  0.2  to  0.45  mV.  Genetic  analysis  of  the  SCN5A  gene
n  the  father  did  not  reveal  any  mutation  in  the  full  coding
equence  or  at  the  exon-intron  boundaries.  The  coding  and
anking  intronic  regions  of  other  genes  recently  reported  to
e  linked  with  BS,  namely  SCN1B, KCNE3  and  SCN3B, were
lso  sequenced  and  no  mutation  was  observed  in  either  the
ather  or  the  son.
The  mother  (aged  41  years)  had  experienced  two  vaso-
agal  episodes  in  the  past.  ECG  at  rest  showed  a type  2
368  J.-S.  Hermida  et  al.
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tigure 1. First family pedigree. A. Baseline electrocardiogram. B
t the second intercostal space. Proband: appearance of J waves in
rugada  pattern  (Fig.  1,  I2).  Ajmaline  challenge  did  not
eveal  any  change  in  precordial  leads  repolarization,  but
howed  a  coved-type  aspect  with  an  ST-segment  eleva-
ion  of  3.5  mV  in  the  inferior  leads.  Genetic  analysis  also
ound  the  SCN5A  p.V1281F  mutation  in  the  mother.  The
.V1281F  mutation  was  not  found  in  a  set  of  162  control
lleles.
econd family
 boy  aged  2.5  years  of  North  African  origin  (Fig.  2,  II3)
as  admitted  following  cardiac  arrest  related  to  ventricular
brillation  in  the  early  morning;  he  had  no  previous  history
f  arrhythmia  and  no  family  history  of  sudden  death.  Long  QT
yndrome  (LQTS)  was  diagnosed  ﬁrst  (QT  500  ms;  QTc  569  ms)
Fig.  3)  and  the  patient  was  treated  with  nadolol  50  mg/m2.
uccessive  ECGs  showed  type  1  Brugada  pattern  (Fig.  4)
ith  persistent  long  QTc  (QTc  615  ms)  on  nadolol.  Echocar-
iography,  hematology  and  biochemistry  examinations  were
ormal.  A  deﬁbrillator  was  implanted.  The  patient  received
wo  successful  appropriate  shocks  from  the  deﬁbrillator  dur-
ng  the  ﬁrst  year  of  follow-up  (Fig.  5).
w
r
mtrocardiogram after ajmaline challenge. V1H, V2H, V1 and V2 lead
inferior leads, amplitude of 1 mm. BS: Brugada syndrome.
The  patient’s  brother  (aged  4  years;  Fig.  2, II2) and  his
alf-sister  (aged  14  years;  Fig.  2,  II1)  were  asymptomatic,
ith  normal  ECGs  at  rest.  Both  parents  were  also  asymp-
omatic:  the  mother  presented  a  type  2  Brugada  ECG  at
est  (Fig.  2, I2)  and  the  father  had  a  normal  ECG  (Fig.  2,
1).
Ajmaline  challenge  in  the  mother  revealed  a  type  1  Bru-
ada  ECG.  The  test  also  provided  positive  results  in  the
ather,  with  evidence  of  type  1  Brugada.  The  SCN5A, SCN1B,
CNE3  and  SCN3B  gene  analysis  did  not  reveal  any  mutation
n  the  proband  or  his  parents.  Also,  LQTS-causing  mutations
n  KCNQ1  and  KCNH2  were  absent.  No  other  ﬁrst-degree
elatives  live  in  France.
iscussion
xhaustive  screening  performed  in  62  families  [3]  identiﬁed
wo  cases  in  which  the  parents  were  both  carriers  for  BS,
ith  one  child  affected  in  each  family.  No  consanguinity  was
eported  in  these  two  families.
The  ﬁrst  family  is  unique  in  that  the  same  SCN5A  p.V1281
utation  appeared  to  have  led  to  the  Brugada  phenotype
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Figure 2. Second family pedigree. A. Baseline electrocardiogram. B. Electrocardiogram after ajmaline challenge. V1H, V2H; V1 and V2
lead at the second intercostal space. Mother’s electrocardiogram: at baseline, QTc 387 ms; after ajmaline challenge, QTc 435 ms. Father’s
electrocardiogram: at baseline, QTc 380 ms; after ajmaline challenge, QTc 440 ms. LQTS: long QT syndrome.Figure 3. Second family proband’s electrocardiogram recorded 4 day
interval 500 ms; QTc interval 569 ms. Nadolol 50 mg/m2 was introduced 4s after cardiac arrest, without hypothermia or hyperthermia. QT
8 hours before.
370  J.-S.  Hermida  et  al.
Figure 4. Second family proband’s electrocardiogram recorded
20 days after cardiac arrest showing J wave, ST-segment elevation
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Table  1  Conserved  SCN5A  V1281  residue  across  species.
V1281  Species
WLDFLIVDVSLVSLVAN  Homo  sapiens
WLDFLIVDVSLVSLVAN  Pan  troglodytes
WLDFLIVDVSLVSLVAN  Macaca  mulatta
WLDFLIVDVSLVSLVAN  Nomascus  leucogenys
WLDFLIVDVSLVSLVAN  Callithrix  jacchus
WLDFLIVDVSLVSLVAN  Cavia  porcellus
WLDFLIVDVSLVSLVAN Heterocephalus  glaber
WLDFLIVDVSLVSLVAN Mus  musculus
WLDFLIVDVSLVSLVAN Rattus  norvegicus
WLDFLIVDVSLVSLVAN Cricetulus  griseus
WLDFLIVDVSLVSLVAN  Sternopygus  macrurus
WLDFLIVDVSLVSLVAN  Danio  rerio
WLDFLIVDVSLVTLVAN  Bos  taurus
WLDFLIVDVSLISLVAN Oreochromis  niloticus
WLDFLIVDVSLISLVAN Canis  lupus  familiaris
WLDFLIVDVSLISLVAN Equus  caballus
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ln V2 and V3 and long QTc interval (615 ms). Patient under nadolol
0 mg/m2.
ither  in  precordial  or  in  inferior  leads.  However,  after
xhaustive  screening  it  appeared  that  each  parent  may  also
ave  transmitted  one  aspect  of  the  Brugada  pattern:  J  point
levation  and  drug-induced  coved-type  in  the  right  precor-
ial  leads  by  the  father  and  a  Brugada  pattern  in  the  inferior
eads  by  the  mother.
The  p.V1281F  mutation  in  the  SCN5A  gene  was  found  in
he  proband  and  his  mother.  The  mutation  was  located  in  the
iddle  of  the  DIII—S2  transmembrane  segment  of  the  protein
nd  is  part  of  the  ion  transport  domain.  Although  there  is  no
unctional  evidence  that  the  mutation  was  responsible  for
he  disease,  valine  to  phenylalanine  replacement  introduces
hanges  in  the  secondary  structure  of  the  DIII—S2  segment  of
he  ion  transport  domain.  Furthermore,  the  V1281  residue
s  highly  conserved  across  species,  as  shown  in  Table  1.
he  SCN5A  p.V1481F  mutation  has  also  been  described  in
 glioblastoma  tumour  as  a  somatic  mutation  [5].
Several  cases  of  Brugada  pattern  in  the  inferior  leadsave  already  been  published  [6—8].  A  type  1  pattern  is
enerally  associated  in  right  precordial  leads,  sometimes
evealed  by  class  I  antiarrhythmic  drugs.  The  study  by
t
t
eWLDFLIVDVSLISLVAN Loxodonta  africana
arkozy  et  al.  [7]  found  a  coved-type  Brugada  pattern  in
he  inferior  leads  in  4.3%  of  the  BS  study  population.  Their
tudy  reported  three  patients  (1%  of  the  population  with  BS)
n  whom  the  ≥  2  mm  coved  ST-segment  elevation  was  only
resent  in  the  inferior  leads.
The  appearance  of  J wave  in  the  inferior  leads  in  the
on  was  suggestive  of  phenotypic  expression  of  the  maternal
orm.  Early  repolarization  pattern  in  the  inferolateral  leads
s  not  uncommon  in  BS  and  has  been  described  by  Letsas
t  al.  [9].  Nevertheless,  this  pattern  should  not  be  assimi-
ated  to  early  repolarization  syndrome,  in  which  the  J  wave
ould  tend  to  disappear  with  ajmaline  [10,11]. It  should  be
oticed  that  Antzelevitch  and  Yan  proposed  to  group  these
wo  entities  under  the  term  ‘J  wave  syndromes’  [12],  but  no
onsensus  has  been  reached  concerning  this  classiﬁcation.
In  the  second  family,  the  severity  and  early  presentation
t  age  2.5  years  are  likely  to  be  related  to  co-inheritance
rom  both  affected  parents.  However,  despite  the  associa-
ion  between  LQTS  and  BS,  no  SCN5A  mutation  was  detected
n  this  case.  The  association  of  BS  and  LQTS  has  been
reviously  described  [13—15]  and  is  caused  by  either  a  com-
ination  of  two  mutations  or  a  single  mutation.  For  example,
he  insertion  of  an  aspartic  acid  residue  at  position  1795  in
CN5A  was  found  in  a  family  with  ECG  signs  of  both  LQTS  and
S  [14]. A  mixed  phenotypic  expression  can  be  observed  in
utations  associated  with  both  gain  and  loss  of  function.
ostema  et  al.  [16]  also  reported  an  interesting  associa-
ion  between  LQTS  and  BS,  in  which  mutation  analysis  was
ifﬁcult  to  interpret.
The  study  by  Probst  et  al.  [17]  highlighted  the  com-
lex  association  between  BS  ECG  and  carriership  of  an
CN5A  mutation.  They  found  eight  patients  with  Brugada-
ype  ECG,  but  without  the  SCN5A  familial  mutation  in  5/13
tudied  families.  They  concluded  that  disparate  genetic
ackgrounds  confer  susceptibilities  to  the  effects  of  a  single
oss-of-function  mutant  sodium  channel.  Nevertheless,  the
ransmission  of  various  aetiologic  forms  of  sudden  death  by
wo  parents  has  been  previously  described,  reminding  that
ven  if  a  genetic  mutation  is  known  to  cause  disease  rhythm,
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lar ﬁ
[Figure 5. Electrogram recordings showing the onset of ventricu
cardiac deﬁbrillator.
other  genetic  abnormalities  may  co-exist  in  the  same  fam-
ily  [18,19].  This  possibility  should  be  taken  into  account
when  analysing  phenotype-genotype  correlations  and  may
explain  why  some  patients  with  a  BS-type  ECG  do  not  carry
the  familial  SCN5A  mutation.  In  the  study  by  Probst  et  al.
o
f
dbrillation and the appropriate shock delivered by the implanted
17], screening  of  both  parents  has  been  performed  in  none
f  the  13  probands.
The  possibility  of  dual  transmission  also  has  implications
or  interpretation  of  whole  exome/genome  experiments
esigned  to  identify  new  BS-associated  genes,  and  for
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enetic  counseling.  In  the  latter  case,  absence  of  the
amilial  SCN5A  mutation  in  a  relative  should  not  pre-
lude  ajmaline  testing  when  screening  of  both  parents  of
 proband  could  not  be  achieved.
tudy limitations
ue  to  the  fact  that  the  presence  of  a  gene  mutation  is
ot  constant  in  this  syndrome,  the  diagnostic  value  of  a
rugada-type  response  in  asymptomatic  patients  is  not  fully
stablished.  Possibility  of  false-positive  responses  to  ajma-
ine  challenges  is  plausible.  It  is  possible  that,  in  some  cases,
rug-induced  Brugada  ECG  may  be  due  to  acquired  individual
usceptibilities  as  a  result  of  a  latent  ion  channel  dysfunc-
ion,  similar  to  that  in  drug-induced  LQTS.
SCN5A  remains  the  most  common  BS  genotype  but
ccounts  for  only  20%  of  all  cases  of  BS.  Other  causes  of  BS
nclude  mutation  in  nine  other  genes,  each  of  them  account-
ng  for  about  1%  of  BS  carriers  [20].  We  have  only  studied
our  genes  in  the  ﬁrst  family  and  six  genes  in  the  second
amily  and  cannot  exclude  that  one  of  the  other  remaining
enes  is  responsible  for  the  disease  in  ‘genotype-negative’
atients.  We  also  cannot  exclude  an  oligogenic  inheritance
echanism  in  these  two  families.
onclusion
his  study  highlights  the  complex  genetics  of  BS,  which  does
ot  seem  to  be  a  purely  ‘autosomal  dominant’  disease.  When
S  or  overlapping  BS  phenotype  is  diagnosed  in  an  individ-
al,  careful  phenotypic  screening  should  be  carried  out  in
he  family  members.  In  particular,  the  discovery  of  a  par-
nt  carrier  for  BS  does  not  eliminate  the  need  for  screening
n  the  other  parent.  Dual  transmission  may  explain  certain
are  phenocopies  or  overlapping  syndrome  and  may  have  an
dditive  role  in  the  severity  of  BS.
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